|Day Low/High||36.08 / 36.76|
|52 Wk Low/High||17.10 / 37.92|
Portfolio manager David Peltier analyzes a volatile, low-dollar drug stock.
Portfolio manager David Peltier finds a pharmaceutical name that is quietly growing faster than its peers.
Adrian Adams, CEO of Auxilium, discusses the company's breakthrough with Xiaflex, as well as recent news surrounding its drug Testim.